Content about Methadone

March 1, 2011

Physicians are 30% more likely to prescribe a drug that gives patients incentives to remain adherent to it than they are to prescribe a drug without such a program, according to a new survey.

NEW YORK — Physicians are 30% more likely to prescribe a drug that gives patients incentives to remain adherent to it than they are to prescribe a drug without such a program, according to a new survey.

The survey of 100 doctors, sponsored by HealthPrize Technologies and conducted by pharmaceutical marketing firm HealthcarePanel.org, also found 89% of doctors were comfortable with the idea of rewarding patients for adherence, along with using education.

January 11, 2011

While a majority of physicians are comfortable with generic medications, there is a small segment who still have negative perceptions about the effectiveness and quality of generic drugs, and that may lead to doctors prescribing unnecessarily expensive medications, according to a new study by researchers at Harvard University, Brigham and Women's Hospital and CVS Caremark.

WOONSOCKET, R.I. — While a majority of physicians are comfortable with generic medications, there is a small segment who still have negative perceptions about the effectiveness and quality of generic drugs, and that may lead to doctors prescribing unnecessarily expensive medications, according to a new study by researchers at Harvard University, Brigham and Women's Hospital and CVS Caremark.

December 3, 2010

At Drug Store News’ Specialty Pharmacy Roundtable event last Tuesday, Diplomat Specialty Pharmacy president and CEO Phil Hagerman remarked that improving medication adherence in specialty pharmacy could be equivalent to a new blockbuster drug. And he may be right.

November 21, 2010

An intensive cancer patient management program by Walgreens’ specialty pharmacy professionals could save health plan...

DEERFIELD, Ill. An intensive cancer patient management program by Walgreens’ specialty pharmacy professionals could save health plan payers $2,000 to $4,000 per patient each month, the company announced.

November 10, 2010

The Food and Drug Administration has approved a drug for treating excess fat development in...

SILVER SPRING, Md. The Food and Drug Administration has approved a drug for treating excess fat development in patients with HIV, the agency said Thursday.

 

The FDA approved Egrifta (tesamorelin) for treating HIV patients with lipodystrophy, a condition in which excess fat develops in different areas of the body, such as the abdominal organs. The condition is often a side effect of the retroviral drugs used to treat the disease.

 

 

November 7, 2010

Patients with rheumatoid arthritis derive about as much benefit from a weekly injection of a...

NEW YORK Patients with rheumatoid arthritis derive about as much benefit from a weekly injection of a biotech drug made by Bristol-Myers Squibb for the disease as they do from receiving it via IV on a monthly basis, according to late-stage clinical trial data released Monday.

October 14, 2010

During the Academy of Managed Care Pharmacy 2010 Educational Conference held Oct. 13 to 15,...

WHAT IT MEANS AND WHY IT'S IMPORTANT During the Academy of Managed Care Pharmacy 2010 Educational Conference held Oct. 13 to 15, CVS Caremark shared data to further demonstrate ways to curb drug costs. This is important because what these studies, and others like it, continue to illustrate is that there are a variety of ways to reduce prescription drug costs beyond simply cutting prices to levels that could compromise a pharmacy's ability to deliver the high-quality service necessary to achieve better health outcomes.

October 12, 2010

The Food and Drug Administration approved a drug to treat and prevent relapse after patients...

SILVER SPRING, Md. The Food and Drug Administration approved a drug to treat and prevent relapse after patients with opioid dependence have undergone detoxification treatment.

Vivitrol is an extended-release formulation of naltrexone -- which works to block opioid receptors in the brain -- administered by intramuscular injection once a month. It only is administered by a physician.

 

September 12, 2010

The Food and Drug Administration did not completely withdraw from the market a drug used...

PHILADELPHIA The Food and Drug Administration did not completely withdraw from the market a drug used to treat a dangerous low blood pressure condition, but merely proposed to do so as a “step in the regulatory process,” according to a document posted on the agency’s website Monday.

The agency said its proposal last month to withdraw approval for Shire’s drug ProAmatine (midodrine) did not represent the actual withdrawal of the drug from the market, while calling for more data on the drug to verify its clinical benefit.

 

August 31, 2010

Improving medication adherence will require bringing multiple methods together in order to be successful, Pharmacy...

SAN DIEGO Improving medication adherence will require bringing multiple methods together in order to be successful, Pharmacy Quality Alliance senior director for research and performance measurement David Nau said Tuesday in an education session at the National Association of Chain Drug Stores’ Pharmacy and Technology Conference in San Diego.

 

“You need to have a multifaceted strategy around adherence if you want to have an impact on adherence,” Nau said.

 

 

August 11, 2010

Prescription drug abusers who go “doctor shopping” in search of prescriptions will face a new...

August 9, 2010

Drug maker Angelini Labopharm has launched a new treatment for depression....

July 21, 2010

A healthy relationship with a community pharmacist can improve health outcomes for patients and save...

RALEIGH, N.C. A healthy relationship with a community pharmacist can improve health outcomes for patients and save money, a new collaborative study from North Carolina-based Kerr Drug and the University of North Carolina revealed.

Those benefits stem from direct interventions in patient therapy by pharmacists, coupled with a coordinated approach to the patient’s treatment regimen by his or her pharmacist and doctor, according to Kerr.

June 23, 2010

The Food and Drug Administration has approved a new drug by Merck for treating asthma...

June 17, 2010

Emergency room visits due to abuse of prescription pain relievers more than doubled between 2004...

June 3, 2010

Now, it’s up to the doctors....

WHAT IT MEANS AND WHY IT'S IMPORTANT Now, it’s up to the doctors.

(THE NEWS: DEA allows controlled drug e-prescribing, handing pharmacy advocates a key victory. For the full story, click here)

May 23, 2010

Most surveyed physicians who have prescribed a dual-acting opioid painkiller made by Johnson & Johnson...

May 16, 2010

The Food and Drug Administration has approved a new nasal spray for treating pain....

May 9, 2010

Allergy sufferers can save money and receive quality, convenient care by skipping the emergency room...

INDIANAPOLIS Allergy sufferers can save money and receive quality, convenient care by skipping the emergency room and instead visiting a retail-based or urgent-care clinic, according to a recent study.

The study conducted by HealthCore, WellPoint’s outcomes research subsidiary, found that patients can save anywhere from $50 to $400 in out-of-pocket costs per visit by skipping the ER and heading to a retail health- or urgent-care clinic when they are unable to see their primary care physician.

March 14, 2010

It’s not like I’m not one of those conspiracy theorists. But I’m also not stupid...

It’s not like I’m not one of those conspiracy theorists. But I’m also not stupid enough to think that Lee Harvey Oswald was a good enough shot to have acted alone, either.

That’s kind of the way I have felt these past few weeks since the American Academy of Family Physicians suddenly reversed its official policy on retail clinics. The AAFP no longer will enter into agreements like the ones it previously held with Minute Clinic, Rediclinic, The Little Clinic and BellinHealth Fast Care, the group announced Feb. 24.

February 28, 2010

GlaxoSmithKline has identified more than 5,500 rare diseases it potentially could target as part of...

February 10, 2010

AmerisourceBergen will use a set of cell phone and Web applications to increase medication adherence...

January 20, 2010

Buying medicine by mail may encourage patients to stick to their doctor-prescribed medication regimen, new...

January 11, 2010

A drug made by Boehringer Ingelheim for treating Parkinson’s disease could have sales of up...

January 10, 2010

Surescripts, the electronic prescribing company founded in 2001 by the National Association of Chain Drug...